A stem cell transplant is a common treatment for multiple myeloma. If you’re able to have one, you’ll get induction therapy followed by a high dose of a chemotherapy drug to kill as many cancer cells as possible. Or your doctor might give you a combination of some of the other medici...
The role of chemotherapy in the treatment of multi- ple myeloma. Baillieres Clin Haematol 1995;8:783-794.Bergsagel, D.E. (1995) The role of chemotherapy in the treatment of multiple myeloma. Clinical Haematology, 8, 783-794.Bergsagel DE.The role of chemotherapy in the treatment of ...
[Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy] Sezaki T, Ishii H, Adachi T, Takahashi I, Ohnoshi T, Kimura I. Tatsuo SEZAKI,Hirofumi ISHII,Tomiroh ADACHI,... - 《Rinshō ...
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis Bortezomib is a proteasome inhibitor for the treatment of relapsed/refractory multiple myeloma (MM). Mechanisms of resistance to Bortezomib are undefined. ... K Podar,SL Gouill,J Zhang,... - 《Oncogene》 被引量: 205发表: 2008年 New...
With current mix of patients, stem cell treatment for multiple myeloma is not cost effective at a threshold of GDP per capita. It becomes marginally cost-effective at 3-times the GDP per capita threshold. However, accounting for the model uncertainties, the probability of ASCT to be cost ...
Limited progress in the treatment of multiple myeloma (MM) has been obtained since the introduction of melphalan more than 20 years ago.Response rates to conventional therapy are only in the order of 50% and median survival averages two to three years. Prognosis is related to tumor load at ...
Multiple Myeloma Precursor More Common Among Black Patients Direct-Acting Antiviral Combination Therapies Can Become Novel Therapeutic Standard in HCV Treatment Female Intravenous Drug Users Have Higher Rates of HCV Infection Due to Riskier Habits
An update on drug combinations for treatment of myeloma. Multiple myeloma is the second most common haematological malignancy. It is becoming increasingly manageable with conventional and high-dose chemotherapy b... M Srikanth,FE Davies,GJ Morgan - 《Expert Opinion on Investigational Drugs》 被引量:...
Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol 1992; 10:334-... WM Gregory,MA Richards,JS Malpas - 《Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology》 ...
The research within the last several years in vitro and in vivo (animal models) showed that curcumin can sensitize cancer cells to different chemotherapeutic agents that are commonly used for Multiple Myeloma treatment. Curcumin up regulates caspase family proteins and down regulates antiapoptotic genes...